Role of pharmacology in optimisation of antibiotic therapy

Antibiotiques

Volumn 3, Issue 1, 2001, Pages 17-26

  Garraffo, R ^a  

^a UNIVERSITY HOSPITAL OF NICE   (France)

Author keywords

Antibiotics; Pharmacodynamics; Resistance; Therapeutic drug monitoring pharmacokinetics

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; KETOLIDE; MACROLIDE; POLYPEPTIDE ANTIBIOTIC AGENT; QUINOLINE DERIVED ANTIINFECTIVE AGENT; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; AREA UNDER THE CURVE; ARTICLE; BACTERICIDAL ACTIVITY; CLINICAL PRACTICE; DOSE TIME EFFECT RELATION; DRUG ACCUMULATION; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG MONITORING; HUMAN; IN VIVO STUDY; PHARMACODYNAMICS; SIDE EFFECT; TREATMENT FAILURE;

EID: 0035101003     PISSN: 12945501     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Rapid increase of pneumococal resistance to beta-lactam and other antibiotics in isolates from the respiratory tract
2. Antibiotic assays in muscle: Are conventional tissue levels misleading as indicator of the antibacterial activity?
3. Relationship between serum concentrations of antibacterial drugs and the outcome of bacterial infections
4. Individualizing drug dosage regimens: Role of population pharmacokinetic and dynamic models, bayesian fitting and adaptative control
5. Role of pharmaocokinetics in the outcome of infections
6. Mathematical examination of dual individualization principles (1): Relationships between AUC above MIC and area under the inhibitory curve for cefmenoxime, ciprofloxacin and tobramycin
7. Antibiotic tissue penetration and its relevance: Models of tissue penetration and their meaning
8. General principles of antibiotic tissue penetration
9. Postantibiotic effects
10. Pharmacokinetics and pharmacodynamics of newer macrolides
11. Correlation of antimicrobial pharmacokinetic parameters with therapeutic efficacy in an animal model
12. Comparative antibiotic dose-effects relations at several dosing intervals in murine pneumonitis and thigh-infection models
13. Pharmacodynamics of antibiotics in fibrin clots
14. Evaluation of intravenous ciprofloxacin in patients with lower respiratory tract infections: Impact of plasma concentrations, organism, MIC and clinical condition on bacterial eradication
15. Choosing an antibiotic on the basis of pharmacodynamics
16. The importance of pharmacokinetic/pharmacodynamic surrogate markers to outcome
17. A critical revaluation of the « therapeutic range » of aminoglycosides
18. Comparative study with enoxacin and netilmicin in a pharmacodynamic model to determine importance of ratio antibiotic peak concentration to MIC for bactericidal activity and emergence of resistance
19. Pharmacodynamics of a fluoroquinolone antimicrobial agent in a neutropenic rat model of Pseudomonas sepsis
20. Pharmacodynamics of levofloxacin: A new paradigm for early clinical trials
21. Pharmacodynamics of intravenous cipro-floxacin in seriously ill patients
22. Pharmacodynamic evaluation of factors associated with the development of bacterial resistance in acutely ill patients during therapy
23. Antibiotics selection factors and description of a hospital-based outpatient antibiotic program in the USA
24. Continous infusion of beta-lactam antibiotics
25. Continous infusion of beta-lactam antibiotics